By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Institute for Systems Biology has contracted Complete Genomics to sequence 615 complete human genomes as part of a study on neurodegenerative diseases, Complete Genomics said today.

Under the agreement, ISB will work with its academic partners to provide Complete Genomics with DNA samples from families in which multiple individuals are affected by neurodegenerative diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.